Evidence map›Paper›PMID 27733134›Full record

ArticleBMC infectious diseases2016

Risk factors for mortality among malnourished HIV-infected adults eligible for antiretroviral therapy.

Susannah L Woodd, Paul Kelly, John R Koethe, George Praygod, Andrea M Rehman, Molly Chisenga, Joshua Siame, Douglas C Heimburger, Henrik Friis, Suzanne Filteau

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 3 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 3 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 5 countries.

Susannah L WooddFaculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
Paul KellyBarts & the London School of Medicine and Queen Mary University of London, London, UK.
John R KoetheVanderbilt University, Nashville, USA.
George PraygodNational Institute for Medical Research, Mwanza, Tanzania.
Andrea M RehmanFaculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK. andrea.rehman@lshtm.ac.uk.
Molly ChisengaUniversity Teaching Hospital, Lusaka, Zambia.
Joshua SiameUniversity Teaching Hospital, Lusaka, Zambia.
Douglas C HeimburgerVanderbilt University, Nashville, USA.
Henrik FriisUniversity of Copenhagen, Copenhagen, Denmark.
Suzanne FilteauFaculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
University of London · GBUniversity Teaching Hospital · ZMVanderbilt University · USNational Institute for Medical Research · TZQueen Mary University of London · GBUniversity of Copenhagen · DK

Funding

Medical Research Council MR/K012126/1
6 · The paper itself

Abstract

backgroundA substantial proportion of HIV-infected adults starting antiretroviral therapy (ART) in sub-Saharan Africa are malnourished. We aimed to increase understanding of the factors affecting their high mortality, particularly in the high-risk period before ART initiation.

methodsWe analysed potential risk factors for mortality of Zambian and Tanzanian participants enrolled in the NUSTART clinical trial. Malnourished adults (n = 1815; body mass index [BMI] <18.5 kg/m

resultsThe mortality rate was higher in the period from referral to starting ART (121 deaths/100 person-years; 95 % CI 103, 142) than during the first 12 weeks of ART (66; 95 % CI 57, 76) and was not affected by trial study arm. In adjusted analyses, lower CD4 count, BMI and mid-arm circumference and raised C-reactive protein were associated with an increased risk of mortality throughout the study. Male sex and lower hand-grip strength carried an increased risk in the pre-ART period. Participants on tuberculosis treatment at referral had a lower mortality rate (adjusted Rate Ratio 0.44; 95 % CI 0.31, 0.63).

conclusionAmong malnourished ART-eligible adults, pre-ART mortality was twice that in the early post-ART period, suggesting many early ART deaths represent advanced HIV disease rather than treatment-related events. Therefore, more efforts are needed to promote earlier diagnosis and immediate initiation of ART, as recently recommended by WHO for all persons with HIV worldwide. The positive effect of tuberculosis treatment suggests undiagnosed tuberculosis is a contributor to mortality in this population.

trial registrationPan African Clinical Trials Registry, PACTR201106000300631 ; registered on 1st June 2011.

Indexed as

AdultAnti-HIV AgentsCD4 Lymphocyte CountFemaleHIV InfectionsHumansMaleMalnutritionPoisson DistributionProportional Hazards ModelsRisk FactorsAnti-HIV AgentsAfricaARTMalnutritionMortality risk factors

Identifiers

PMID27733134
PMCPMC5062813
OpenAlexW2531893192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.